Ets-1 Gene Expression in Patients with Thymoma

Japanese Journal of Thoracic and Cardiovascular Surgery

Volumn 50, Issue 12, 2002, Pages 503-507

  Sasaki, Hidefumi ^a   Kobayashi, Yoshihiro ^a   Tanahashi, Masayuki ^a   Yukiue, Haruhiro ^a   Yano, Motoki ^a   Kaji, Masahiro ^a   Kiriyama, Masanobu ^a   Fukai, Ichiro ^a   Yamakawa, Yosuke ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Ets 1; Invasion; Light Cycler; Thymoma

Indexed keywords

MESSENGER RNA; PROTEINASE; TRANSCRIPTION FACTOR ETS 1; ETS1 PROTEIN, HUMAN; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS;

ADULT; AGE; AGED; ANALYZER; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CELL FUNCTION; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE ACTIVITY; ENZYME ACTIVATION; FEMALE; FLUOROMETRY; GENDER; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; METASTASIS; PATHOGENESIS; PREDICTION; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYMOMA; ARTICLE; BIOSYNTHESIS; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYMOMA; THYMUS NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0036985724     PISSN: 13444964     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02913162     Document Type: Conference Paper

References (28)

1. Levine GD, Rosai J. Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 1978; 9: 495-515.
2. Souadjian JV, Enriquez P, Silverstein MN, Pepin JM. The spectrum of disease associated with thymoma: coincidence or syndrome? Arch Intern Med 1974; 134: 374-9.
3. Rosenow EC III, Hurley BT. Disorder of the thymus; a review. Arch Intern Med 1984; 144: 763-70.
4. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-4.
5. Mattern M, Koomagi R, Volm M. Vascular endothelial growth factor expression and angiogenesis in non-small-cell lung carcinoma. Int J Oncol 1995; 6: 1059-62.
6. Kondo K, Kinoshita H, Ishikura H, Miyoshi T, Hirose T, Matsumori Y, Monden Y. Activation of matrix metalloproteinase-2 is correlated with invasiveness in thymic epithelial tumors. J Surg Oncol 2001; 76: 169-75.
7. Mori M, Barnard GF, Mimori K, Ueo H, Akiyoshi T, Sugimachi K. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer (Phila) 1995; 75: 1516-9.
8. Westermarck J, Kahari VM. Regulation of matrix melalloproteinase expression in tumor invasion. FASEB J 1999; 13: 781-92.
9. Wasylyk B, Hahn SL, Giovane A. The Ets family of transcription factors. Eur J Biochem 1993; 211: 7-18.
10. Sharrocks AD, Brown AL, Ling Y, Yates PR. The ETS-domain transcription family. Int J Biochem Cell Biol 1997; 29: 1371-87.
11. Westermarck J, Seth A, Kahari VM. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 1997; 14: 2651-60.
12. Wasylyk C, Gutman A, Nicholson R, Wasylyk B. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several nonnuclear oncoproteins. EMBO J 1991; 10: 1127-34.
13. Kola I, Brookes S, Green AR, Garber R, Tymmus M, Papas T, et al. The Etsl transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA 1993; 90: 7588-92.
14. Ozaki I, Mizuta T, Zhao G, Yotsumoto H, Hara T, Kajihara S, et al. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res 2000; 60: 6519-25.
15. Tsutsumi S, Kuwano H, Asao T, Nagashima K, Shimura T, Mochiki E. Expression of Ets-1 angiogenesis-related protein in gastric carcinoma. Cancer Lett 2000; 160: 45-50.
16. Saeki H, Kuwano H, Kawaguchi H, Ohno S, Sugimachi K. Expression of Ets-transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus. Cancer 2000; 89: 1670-6.
17. Nakayama T, Ito H, Ohtsuru A, Naito S, Sekine I. Expression of the ets-1 proto-oncogene in human colorectal carcinoma. Mod Pathol 2001; 14: 415-22.
18. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 1997; 22: 176-81.
19. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymoma with special reference to its clinical stages. Cancer 1981; 48: 2485-92.
20. Sasaki H, Yukiue H, Moriyama S, Kobayashi Y, Nakashim Y, Kaji M, et al. Clinical significance of matrix metalloproteinase-7 and ets-1 gene expression in patients with lung cancer. J Surg Res 2001; 101: 242-7.
21. Pande P, Soni S, Chakravarti N, Mathur M, Shukla NK, Ralhan R. Prognostic impact of Ets-1 overexpression in bete1 - and tobacco - related oral cancer. Canc Detect Prev 2001; 25: 496-501.
22. Davidson B, Risberg B, Goldberg I, Nesland JM, Berner A, Trope CG, et al. Ets-1 mRNA expression in effusion of serous ovarian carcinoma patients is a marker of poor outcome. Am J Surg Pathol 2001; 25: 1493-500.
23. Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, et al. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin Cancer Res 2001; 7: 451-3.
24. Takanami I, Takeuchi K, Karuke M. Expression of Ets-1 is correlated with urokinase-type plasminogen activator and poor prognosis in pulmonary adenocarcinoma. Turn Biol 2001; 22: 205-10.
25. Yamamoto H, Adachi Y, Itoh F, Iku S, Matsuno K, Kusano M, et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal carcinoma. Cancer Res 1999; 59: 3313-6.
26. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, et al. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999; 18: 2883-91.
27. Cox G, Jones JL, Obyrne KJ. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small-cell lung cancer. Clin Cancer Res 2000; 6: 2349.
28. Gilhus NE, Jone M, Turley H, Gatter KC, Nagvekar N, Newson-Davis J, et al. Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen. J Clin Pathol 1995; 46: 447-55.